RPE-derived extracellular matrix improves graft retention and photoreceptor preservation in preclinical models of retinal degeneration Authors: Fatemeh Sadat Hosseini Mazinani, Mohammad Kazemi Ashtiani, Azadeh Moradmand, Leila Satarian Published: 2026 ABSTRACT AbstractIntroductionHuman pluripotent stem cells-derived retinal pigment epithelium (hPSC-RPE) represent a promising therapeutic approach for macular degeneration. This study examines whether RPE–derived extracellular matrix (RPE-ECM), enhances survival and functional outcomes following hPSC-RPE suspension transplantation in a preclinical model of retinal degeneration.MethodshPSC-RPE cells were cultured under three conditions: control, RPE-conditioned medium (RPE-CM), and RPE-ECM. In vitro, the cells were assessed for proliferation, monolayer organization, and gene expression. In vivo, GFP-labeled hPSC-RPE cells were co-transplanted with the corresponding treatments into the subretinal space of a mouse model of retinal degeneration. For functional assessment, the cells were injected into RCS rats, with visual acuity tracked over six months using optomotor response testing. Retinal morphometry was analyzed by immunohistology techniques to evaluate graft integration and structural rescue.ResultsIn vitro, culture of hPSC-RPE cells with RPE-ECM enhanced proliferation and promoted monolayer formation, and increased Nidogen expression. In vivo, co-transplantation with RPE-ECM significantly improved mice retinal graft integration (47.1% vs. 3.6% in control, P < 0.001) and visual acuity over four months in RCS rats. RPE-derived ECM improved graft retention and photoreceptor preservation observed at 180 days (P < 0.001), with neuroprotective effects extending beyond the graft site to the contralateral retina.ConclusionThese findings suggest that co-transplantation with RPE-ECM enhances the integration and function performance of hPSC-RPE cells and may represent a promising strategy to improve graft viability within the host retina. Nevertheless, this study has several limitations, including short-term assessment in animal models and the lack of detailed ECM compositional analysis. Further studies are required to elucidate the underlying mechanisms and to evaluate the long-term transplantation potential of this approach in clinical settings.Keywords: Retinal pigmented epithelium, Cell integration, Extracellular matrix, Co-transplantation Introduction Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss worldwide [1]. Transplantation of human pluripotent stem cell-derived retinal pigment epithelial (hPSC-RPE) cells represents a promising therapeutic strategy for AMD. Previous preclinical and clinical studies have demonstrated the safety and potential efficacy of hPSC-RPE–based therapies for retinal degeneration [2], [3], [4]. However, limited survival and poor integration of transplanted cells remain key barriers to achieving consistent clinical outcomes. To date, three main strategies have been explored for hPSC-RPE transplantation: (i) cell suspension injection, (ii) monolayer sheet transplantation, and (iii) scaffold-based RPE patch approaches [3], [5]. Although cell suspension delivery is surgically less invasive and faster, it is associated with poor long-term survival and limited integration of transplanted cells [6], [7], [8], [9]. A major contributing factor is the loss of extracellular matrix (ECM)–mediated adhesion. Under physiological conditions, RPE cells attach to Bruch's membrane (BM), a specialized ECM rich in elastin and collagen, and form a functional monolayer essential for survival and function [10] However, in AMD, Bruch's membrane undergoes significant biochemical and structural alterations, including protein cross-linking, lipid accumulation, and increased thickness, which impair effective cell–matrix interactions [11]. These changes can trigger anoikis, a form of programmed cell death resulting from loss of ECM attachment [12]. To improve transplanted cell survival, recent efforts have increasingly focused on RPE sheet and patch-based transplantation approaches. Although these strategies enhance cell survival and integration compared with cell suspensions, they remain limited by surgical complexity and challenges related to biocompatibility [6], [13]. Therefore, there is a critical need to develop alternative strategies that promote long-term survival and functional integration of transplanted RPE cells. Previous studies have highlighted the potential of ECM–based approaches to enhance the survival, integration, and functional adaptation of transplanted cells across multiple tissue platforms [14]. For instance, ECM co-transplantation has been shown to improve cardiomyocyte survival and engraftment [15], while restoration of damaged ECM has been proposed to support cell viability and function [16], [17]. These beneficial effects are attributed to the ability of the ECM to provide essential biochemical and biophysical cues that regulate cell adhesion, survival, and functional maturation [18]. In addition, the ECM acts as a reservoir for growth factors and signaling molecules that modulate cell behavior and contribute to tissue remodeling [19]. In this experimental study, RPE-derived ECM was selected for its biomimetic properties in RPE transplantation. Both in vitro and in vivo studies have shown that RPE-ECM contains key components, including laminin, collagen, and hyaluronic acid, which are essential for maintaining retinal structural and functional integrity [20], [21]. Based on this rationale, we hypothesized that co-transplantation of hPSC-RPE cells with RPE-ECM would enhance cells survival, integration, and functional performance following transplantation in preclinical models of retinal degeneration. Materials and methods Ethical approval and study design All experimental procedures involving human-derived cells and animals were conducted in accordance with institutional ethical guidelines and were approved by the relevant ethics committee (IR.ACECR.ROYAN.REC.1397.266). Culturing of hPSC-RPE cells and its ECM preparation The established hESC-RPE (Royan H6; RH6) and GFP-labeled hiPSC-RPE (CAG-GFP-chr13-hetero, XCell Science) cell lines had been previously deposited in the Royan Stem Cell Bank [22], [23], [24]. After thawing, cells in Passage 1 were seeded at a density of 5 × 104 cells/cm2 on 4-well plates coated with Laminin 521 (BioLamina). Then, RPE cells were cultured in a medium consisting of Advanced Dulbecco's Modified Eagle Medium supplemented with 20% KnockOut Serum Replacement and 1% GlutaMax, at 37 °C in a humidified atmosphere with 5% CO2. All mediums prepared from Thermo Fisher Scientific, Gibco. The medium was changed every 2–3 days. After 72 h, conditioned medium derived from hPSC-RPE cultures (RPE-CM) was collected and stored at −70 °C for subsequent experiments. To generate RPE-ECM, 1 × 105 cells/cm2 hESC-RPE cells were cultured for 30 days. The cell layers were washed three times with phosphate-buffered saline (PBS) and then incubated with ddH2O containing 0.5% Triton X-100 (Sigma-Aldrich) and 20 mM ammonium hydroxide (NH4OH; Sigma-Aldrich) for 5–10 min at 37 °C [25]. Decellularization was monitored using phase-contrast microscopy. Following cell lysis, the plates were extensively washed 5–10 times with ddH2O to remove cellular debris. The resulting decellularized ECM was air-dried under a laminar flow hood and stored at −20 °C for subsequent experiments. Dried ECM was solubilized by adding either 200 μl of 0.01% Acetic acid, 8 M Urea or 1 mg/mL porcine pepsin in 0.1 N HCl (Sigma- Aldrich) to the culture plates. The matrix was mechanically detached using a cell scraper [26]. RPE-ECM characterization Total protein concentration of the solubilized ECM was quantified using a micro-BCA assay (Thermo Fisher Scientific). The resulting Acetic acid, Urea and pepsin-extracted ECM solutions were collected in sterile microtubes and stored at −20 °C for subsequent experiments. Fibronectin content in native and decellularized RPE-derived matrix samples was quantified with a commercially available sandwich enzyme-linked immunosorbent assay (ELISA) kit (DFB10, R&D Systems), following the manufacturer's instructions. Also, the deposition of Collagen IV was assessed by Immunofluorescence staining. Briefly, samples were fixed in cold 4% paraformaldehyde for 15 min and blocked with 5% Bovine Serum Albumin (BSA) for 1 h at room temperature (RT). Samples were then incubated with Collagen IV antibody overnight at RT, followed by incubation with secondary antibody for 1 h. For quantification of fluorescence intensity, images were acquired under identical exposure and mean gray values were measured using ImageJ software. dsDNA quantification Cellular DNA content was quantified using a Hoechst-based fluorometric assay according to a previously described protocol [18]. Samples were diluted 1:1 with a TNE buffer (10 mM Tris, 2 M NaCl, 1 mM EDTA, pH 7.4) containing 20 μg/ml Hoechst 33258 (Life Technologies). Fluorescence intensity, corresponding to DNA concentration, was measured at an excitation/emission wavelengths of 350/460 nm. Assessment of RPE-ECM effects on hPSC-RPE characteristics To evaluate the effects of RPE-ECM on hPSC-RPE proliferation, monolayer formation, and gene expression, RPE cells were seeded at a density of 5 × 104 cells/cm2 as previously described. After 24 h, the medium was replaced and cells were cultured under four conditions: (1) control, (2) RPE-conditioned medium (RPE-CM, 1:1), (3) RPE-ECM at 1 μg/mL (RPE-ECM 1), and RPE-ECM at 10 μg/ml (RPE-ECM 10). The medium was refreshed every 2 days throughout an 8-day experimental period. Proliferation analysis Cell proliferation was assessed using the Click-iT™ EdU imaging kit (Invitrogen) according to the manufacturer's instructions. On day 7 of culture, cells were incubated with 10 μM EdU for 2 days. Subsequently, culture medium was removed, and cells were fixed with 4% paraformaldehyde (PFA). After washing with 3% bovine serum albumin (BSA), cells were permeabilized with 0.5% Triton X-100 and washed again with 3% BSA. Samples were then incubation with Click-iT™ reaction cocktail for 30 min, followed by nuclear counterstaining with 5 μg/mL Hoechst 33342. Images were acquired using an Olympus IX71 fluorescence microscope with appropriate excitation/emission settings EdU and Hoechst. Proliferation rate was quantified by analyzing 10 random fields per well, and the percentage of EdU-positive cells was calculated and averaged for each condition. Immunocytofluorescence staining and analysis hPSC-RPE cells were fixed with 4% PFA for 10 min at room temperature, washed with PBS, and permeabilized with 0.5% Triton X-100 and 0.5% NP40 (Thermo Fisher Scientific) in PBS for 30 min at 37 °C. Cells were then blocked with 10% normal goat serum for 1 h and incubated overnight with an anti-ZO1 primary antibody. Epithelial organization was quantified using the EpiGraph Fiji plugin [27]. The proportion of hexagonal cells, as an indicator of epithelial structural integrity and functional organization [28], was calculated from five randomly selected fields per group. Preparation of hPSC-RPE cells for transplantation hiPSC-RPE cells were cultured at a density of 5 × 104 cells/cm2 for 8 days in the presence of either RPE-CM (1:1) or 1 μg/ml RPE-ECM. On day 9, the medium was replaced with standard RPE medium, and cells were further cultured for 12 days until a pigmented, polygonal morphology was achieved. Cells were then treated with 10 μM Rock inhibitor Y -27,632 (Sigma-Aldrich) for 1 h at 37 °C. After washing with PBS, cells were detached using TrypLE Express Enzyme (Thermo Fisher Scientific, Gibco) and resuspended in RPE medium. Cells counts were determined using a Neubauer chamber, followed by centrifugation at 1500 rpm for 5 min. Finally, cells were resuspended at concentration of 5 × 104 cells/μl in RPE medium supplemented with either RPE-CM or RPE-ECM, depending on the experimental group. Animals and experimental models In vivo studies were conducted using C57Bl/6 mice (n = 12; male) and dystrophic Royal College of Surgeons (RCS) rats (n = 35; both sexes) as models of retinal degeneration. The 7-day endpoint in the mouse model was selected to evaluate early graft survival in the acute degenerating environment of sodium iodate-induced injury, which precludes long-term assessment. The RCS rat model, with its slower progressive degeneration due to Mertk mutation, enabled long-term evaluation of functional visual recovery and graft integration over 6 months. C57Bl/6 mice (8 weeks old, 20–25 g) were housed under a 12-h light/dark cycle at the Royan Institute of Stem Cell Biology and Technology. Retinal degeneration was induced in C57Bl/6 mice via tail vein injection of sodium iodate (NaIO3, 70 mg/kg; Sigma-Aldrich) under general anesthesia with ketamine-xylazine (100:10 mg/kg, intraperitoneal). This model is widely used for studying RPE cell transplantation in retinal degeneration [29]. Seven days post-injection, animals were randomized to receive 2 μl subretinal injection containing 1 × 105 GFP-labeled RPE cells suspended in RPE medium supplemented with either RPE-CM (1:1) or RPE-ECM (1 μg/ml). In each animal, one eye received the injection, while the contralateral eye served as untreated control. For RCS rats, unilateral subretinal transplantation was performed at postnatal day 21 (P21) using 2 μl of a suspension containing 1 × 105 hiPSC-RPE cells with either RPE-CM (1:1) or RPE-ECM (1 μg/ml). All animals (C57Bl/6 mice and RCS rats) receive daily oral cyclosporine A (210 mg/l; USP) from one day prior to transplantation until sacrificed. In addition, dexamethasone (1.6 mg/kg, intraperitoneal) was administered daily for two weeks post-transplantation. Optomotor response assessment Spatial visual acuity was evaluated using an OptoDrum system (Striatech technologies, Tübingen, Germany). The apparatus consists of a central elevated platform surrounded by four computer monitors displaying rotating black-and- vertical gratings, with a camera positioned above for behavioral recording. Clockwise and counterclockwise rotations selectively evoke optomotor responses in the left and right eye, respectively [2]. Testing began at low spatial frequencies, during which head-tracking movements indicated visual perception of the stimulus. Spatial frequency was then progressively increased until the optomotor reflex was no longer elicited, defining the visual acuity threshold. In RCS rats, visual acuity was assessed at 30, 120, and 180 days post- transplantation. Histology and morphometric analysis All animals were anesthetized, and eyes were enucleated and fixed in 4% PFA for 1 h. Samples were then cryoprotected in PBS containing sucrose (1 mg/mL; MP Biomedicals) at 4 °C prior to cryo-sectioning. Tissues were embedded in optimal cutting temperature (OCT) compound (Agar Scientific) and sectioned at 8 or 16 μm using cryostat (Leica CM1850). For each eye, serial sections were prepared to ensure uniform sampling of the entire retina. GFP-positive graft distribution was quantified using ImageJ by measuring GFP-positive retinal length relative to the total retinal length, providing an index of cell engraftment and spatial integration. This approach specifically captures monolayer integration while minimizing overestimation from clustered aggregates. Outer nuclear layer (ONL) thickness was measured in each group using 4–6 RCS rats. For each rat, one eye received the designated treatment (RPE or RPE-ECM), and the contralateral eye served as an untreated control. After enucleation, treated eyes were sectioned serially at 16 μm thickness, and every 5th section was selected for analysis to avoid re-sampling the same cells. In each selected section, ONL thickness was measured using ImageJ at four distinct retinal regions: central temporal, peripheral temporal, central nasal, and peripheral nasal. To account for variations in section plane and retinal size, all measurements were normalized to the corresponding retinal length from the optic nerve head to the peripheral retinal edge. The four regional measurements were averaged to obtain a single mean ONL thickness value per eye. All measurements were performed by a single investigator blinded to the group allocation; slides were coded, and group identities were revealed only after data collection was complete. General methodological statement Detailed protocols for immunofluorescence staining, RT-qPCR analysis, and subretinal cell transplantation are provided in the Supplementary Materials. Statistical analysis Statistical analyses were performed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA, USA) Data are presented as mean ± standard deviation (SD), and the number of biological replicates (n) is indicated in each figure legend. Normality and homogeneity of variances were assessed using the Shapiro-Wilk test. For normally distributed data, comparisons between two groups were performed using an unpaired two-tailed Student's t-test, and multiple groups comparisons were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. For non-normally distributed data, the Mann-Whitney U test and Kruskal-Wallis test was applied for two-group and multi-group comparisons, respectively. Statistical significance was defined as *P < 0.05, **P < 0.01, ***P < 0.001. Results Extracellular matrix preparation and characterization The RPE-ECM was obtained from confluent polygonal hESC-RPE cells cultured for 30 days, followed by decellularization (Fig. 1A). Successful decellularization was confirmed by the absence of nuclear staining (DAPI) in fluorescence microscopy images (Fig. 1B) and a significant reduction in dsDNA content (Fig. 1C). No significant changes were observed in fibronectin content, while immunostaining confirmed the preservation of collagen IV (Fig. 1D and E). Extraction and characterization of RPE-derived ECM. (A) Schematic of ECM preparation. (B) Phase-contrast image of confluent hPSC-RPE monolayer before decellularization (day 30) and DAPI staining confirming removal of nuclei (scale bar = 100 μm). (C) Quantification of residual dsDNA confirming effective decellularization. (D) Fibronectin levels were preserved after decellularization. (E) Immunostaining showing preservation of collagen IV in the ECM (scale bar = 100 μm). (F) Quantification of collagen IV Florescence intensity using ImageJ Software. (G) Comparison of ECM protein yield across extraction methods. (H) Time-dependent increase in ECM protein deposition with extended culture duration. Statistical analysis: Student's t-test (C, D &F); one-way ANOVA with Tukey's post hoc test (G&H). Data are presented mean ± SD. **P < 0.01, ***P < 0.001. For matrix solubilization, decellularized samples were subjected to different digestion conditions. Pepsin digestion yielded significantly higher protein recovery than Acetic acid or Urea and was therefore selected for subsequent experiments (Fig. 1F; p < 0.001). The effect of culture duration on matrix deposition was also evaluated. Prolonged hESC-RPE culture significantly increased protein accumulation, reaching an approximately eightfold increase at day 210 compared with fourfold increases at days 30 and 120 (Fig. 1G; p < 0.001). RPE-ECM promotes RPE cells expansion and monolayer formation For protein-level confirmation of RPE identity and GFP expression, we performed immunostaining for Ezrin, a key RPE marker. Ezrin is a member of the ERM family that is highly expressed in the apical microvilli of RPE cells and is widely used as an RPE marker. Representative images of Ezrin immunostaining after ECM treatment at 1 and 10 μg/ml are included in the Supplementary Fig. 1, showing Ezrin expression co-localized with GFP and confirming RPE identity. Protein-level confirmation of GFP expression and RPE identity. Representative immunofluorescence images of Ezrin immunostaining in hiPSC-RPE cells after ECM treatment at 1 and 10 μg/ml. Ezrin is shown co-localized with GFP, confirming RPE identity. Nuclei were counterstained with DAPI (scale bar = 100 μm). To evaluate the effects of RPE-ECM on hPSC-RPE viability and proliferation, cells were cultured under four conditions: RPE medium (Control), RPE-conditioned medium (RPE-CM, 1:1), and RPE-ECM at 1 or 10 μg/ml (Fig. 2A). Effect of RPE-derived ECM on hPSC-RPE proliferation and monolayer organization. (A) Experimental scheme showing hPSC-RPE culture under four conditions for 9 days. (B) Representative images of EdU staining. (C) Quantification of EdU-positive cells showing increased proliferation in the RPE-ECM 10 group. (D) Immunofluorescence staining of ZO1 indicating tight junction organization. Enhanced hexagonal morphology of hPSC-RPE monolayers in ECM-treated groups. (E) Quantification using the EpiGraph Fiji plugin showed a significantly higher proportion of hexagonal cells in RPE-ECM 1 and 10 groups. Statistical analysis: one-way ANOVA followed by Tukey's post hoc test. Data are presented mean ± SD. *P < 0.05. Trypan blue exclusion and EdU incorporation assays showed that RPE-ECM (1 &10 μg/mL) did not compromise cell viability and modestly increased proliferation compared with control conditions, while its not significant by effecting RPE conditioned medium (Fig. 2B and C; p < 0.05). Immunofluorescence analysis of ZO1 revealed improved epithelial organization in both ECM-treated groups, characterized by increased hexagonal morphology and cobblestone-like monolayer formation compared with the RPE and RPE-CM groups (Fig. 2D and E; p < 0.05; low-magnification images demonstrating this morphology are provided in Supplementary Fig. 2). Notably, an equal number of cells was seeded in each group at the start of the experiment, ensuring that any differences observed after treatment could be attributed to the treatment itself rather than to seeding density. Importantly, a direct relationship was observed between proliferation rate and cell size after treatment in the ECM-treated group, where proliferation was higher, cells were smaller and underwent epithelialization earlier. As no significant difference in proliferation or epithelialization was observed among the ECM concentrations, 1 μg/mL was selected for subsequent experiments. Quantification of epithelial organization using EpiGraph Fiji. Representative images were analyzed to assess epithelial organization of hPSC-RPE monolayers. The proportion of hexagonal cells was quantified using EpiGraph Fiji plugin across five images per group. ECM-treated groups showed an increased frequency of hexagonal cells compared to controls. qRT-PCR analysis showed no significant differences in the expression of the RPE-related genes associated with structure, maturation, and function (ZO1, BEST1, TYR & VEGF) following treatment with RPE-CM or RPE-ECM compared with control, indicating preservation RPE identity. Among ECM-related genes, no significant changes were observed in FBN2 (Fibrilin-2) and ITGB1(Integrin Subunit Beta 1) expression under treatment conditions. In contrast, NID1 (Nidogen-1) expression was significantly increased in the RPE-ECM group compared with both control and RPE-CM groups (Fig. 3). RT-qPCR analysis of RPE-related gene expression. Quantitative RT-PCR was performed to assess mRNA expression of RPE markers. Treatment with RPE-CM or RPE-ECM did not significantly affect genes associated with RPE identity, ion channel function or pigmentation. However, Nid1 (Nidogen 1) expression was significantly increased in ECM-treated group, suggesting involvement in ECM remodeling. Statistical analysis: Kruskal-Wallis test followed by Dunn's post hoc test. Data are presented as mean ± SD (n = 3 independent sample)., *P < 0.05, **P < 0.01. RPE-ECM enhances transplanted cell integration in the mouse retina To assess the potential of ECM to improve the survival and integration of hPSC-RPE cells in vivo, GFP-labeled hiPSC-RPE cells were pretreated with RPE-CM or RPE-ECM 1 for 8 days and cultured until 21st days post seeding, as schematically outlined in Fig. 4A. A single-cell suspension was then prepared in the presence of RPE-CM or RPE-ECM and transplanted into the subretinal space of NaIO3-injected mice. Seven days after transplantation, retinal sections were analyzed to evaluate the distribution of GFP-labeled cells. The RPE-ECM group exhibited a more intense and broader GFP signal extending across the retina compared with other groups (Fig. 4B). To demonstrate the extent of retinal cell layer degeneration induced by NaIO₃ administration, Supplementary Fig. 3 shows representative H&E-stained retinal cross-sections from a healthy control retina and from retinas harvested at 7 and 14 days after NaIO₃ injection. Quantitative analysis of whole retinas from four eyes per group showed an increase in GFP signal length from 3.6% ±7.3 in the untreated group to 47.1% ± 11.7 in the RPE-ECM group (Fig. 4C; P < 0.001; Supplementary Fig. 4). Enhanced integration of GFP-labeled hiPSC-RPE cells in NaIO3-injected mice following co-transplantation. (A) Schematic of GFP-labeled hPSC-RPE cell preparation for subretinal transplantation. (B) Representative retinal sections showing increased GFP signal in the subretinal space of the RPE-ECM group at 7 days post-transplantation. (C) Quantification of GFP-positive area demonstrating higher graft coverage in the RPE-ECM group compared to controls. (D) Ki67 immunostaining indicating no evidence of proliferation of transplanted GFP-positive cells; nuclei were counterstained with DAPI (scale bar = 100 μm). Statistical analysis: Kruskal-Wallis's test followed by Dunn's post hoc test. Data are presented as mean ± SD. *P < 0.05. Representative H&E stained retinal cross-sections showing the degree of retinal cell layer loss following NaIO₃ injection. Healthy control retina, retina at 7 days post-injection and retina at 14 days post-injection (scale bar = 50 μm). Comparison of GFP-labeled hiPSC-RPE integration after transplantation in NaIO3-injected mice. Representative retinal sections 7 days post-transplantation showing GFP distribution in RPE and RPE-ECM groups. Increased GFP-positive length was observed in the RPE-ECM group compared to RPE controls. Images represent defined retinal segments across the whole globe (160 μm intervals). To determine whether this increase was attributable to enhanced cell proliferation or integration, retinal sections from RPE-ECM group were assessed by Ki67 immunofluorescence. This revealed no significant proliferation of GFP-positive transplanted hiPSC-RPE cells, although some Ki67-positive cells were observed in other retinal layers (Fig. 4D; Supplementary Fig. 5A). Overall, these findings indicate that ECM co-transplantation enhances RPE survival and integration in the mouse model. human transplanted cells in the rat subretinal space. A) Existence of Ki67-positive cells in the contralateral region of transplanted GFP-labeled hiPSC-RPE cells in the retina of NaIO₃-injected mice. Nuclei were counterstained with DAPI (scale bar = 200 μm). B) The fluorescence imaging reveals a monolayer of hiPSC-RPE formed by transplanted human cells in the rat subretinal space, as demonstrated by staining with a human-mitochondria-specific antibody, which overlaps with the GFP-RPE cell monolayer (scale bar = 200 μm). RPE L; Retinal pigmented epithelium layer. (C) Representative images of OPN1MW expression following hiPSC-RPE transplantation, including in the region contralateral to the transplantation site, confirming structural preservation of cone photoreceptors. Nuclei were counterstained with DAPI (scale bar = 50 μm). RPE-ECM enhances visual function and photoreceptor preservation in RCS rats To evaluate whether RPE-ECM improves functional recovery, GFP-labeled hiPSC-RPE cells were transplanted into the subretinal space of postnatal day 21 RCS rats. Visual function was assessed using the optomotor response (OMR) test at 30, 120, and 180 days post transplantation in both group RPE and RPE-ECM. In each animal, one eye received the transplant while the contralateral eye served as an internal control. RPE-ECM co-transplantation significantly improved visual acuity compared with RPE cells alone at day 30 (p < 0.01) and 120 days (p < 0.05), with a sustained but non-significant trend at 180 days (Fig. 5A), accompanied by higher OMR thresholds over. These findings indicate that ECM enhances early and mid-term functional recovery following transplantation. Functional effects of RPE-ECM transplantation in RCS rats. (A) Optomotor response (OMR) showing improved visual acuity in the RPE-ECM group on day 30 and day 120 compared to RPE-only transplantation, with a non-significant trend at day 180. (B, C) Representative retinal sections and quantification of GFP-positive area indicating increased graft survival in the RPE-ECM group. (D) Assessment of photoreceptor preservation based on outer nuclear layer (ONL) thickness measured by DAPI staining. The photoreceptor region is outlined with a red dashed line in the figures (E) Significant preservation in ONL thickness in the RPE-ECM group compared to control, indicating improved photoreceptor survival. Statistical analysis: Mann-Whitney U test. Data are presented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 6 months after hiPSC-RPE transplantation, we examined the presence of human cells in the RCS rat eye sections using immunostaining for the human-mitochondria-specific antibody. The fluorescence emitted by these cells overlapped with a layer of GFP-labeled RPE cells, confirming the presence of human transplanted cells in the subretinal space of the rat retina (Supplementary Fig. 5B). To determine whether improved function correlated with graft survival, the extent of GFP-positive retinal coverage was quantified. RPE-ECM significantly increased graft integration, with approximately a 3.8-fold expansion of GFP-positive retinal length compared with controls (p < 0.05; Figs. 5B–C), indicating enhanced survival and distribution of transplanted cells. Next, photoreceptors preservation was assessed on 180th days post transplantation, by measuring ONL thickness. In agreement with functional outcomes, ONL thickness was significantly increased in the RPE-ECM group compared with controls (p < 0.0001; Figs. 5D–E), suggesting improved structural preservation under degenerative conditions. Interestingly, spatial analysis of ONL preservation relative to graft location revealed increased photoreceptor survival both at the transplantation site (superior retina) and in the contralateral region (inferior retina), with more pronounced rescue observed in the RPE-ECM group (Fig. 6A). To further confirm photoreceptor survival at the graft site and its contralateral region, we used photoreceptor specific antibodies against Rhodopsin, S-Opsin and Opsin 1 (OPN1MW). Fig. 6B and Supplementary Fig. 5C confirm the presence of these proteins in the photoreceptor layer particularly in the superior region, where transplanted GFP-labeled RPE cells were localized adjacent to host photoreceptors. These findings suggest that ECM co-transplantation not only enhances graft integration but may also exert broader neuroprotective effects on host retinal tissue. Distribution of photoreceptor nuclei is relative to transplanted hiPSC-RPE cells. (A) Comparison of photoreceptor nuclei distribution in superior (transplant site) and inferior (contralateral) retinal regions in control and RPE-ECM groups, showing increased preservation in the ECM-treated group. The photoreceptor region is outlined with a yellow dashed line in the figures. (B) Representative immunostaining of photoreceptor cells on both the grafted and contralateral retinal sides with specific photoreceptor antibodies. ONH; Optic nerve head, ONL; Outer Nuclear layer, INL; Inner Nuclear layer. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Discussion In this study, supplementation of RPE-ECM enhanced hESC-RPE cell proliferation in vitro and promoted the formation of a well-organized hexagonal monolayer. Importantly, in vivo co-transplantation of hiPSC-RPE cells with RPE-ECM improved graft integration, attenuated photoreceptor degeneration, and preserved visual function in retinal degeneration models. The beneficial effects of ECM likely reflect its ability to establish a supportive microenvironment that facilitates transplanted cells survival and tissue integration [30]. Preconditioning or co-delivery of cells with ECM has been shown to enhance regenerative capacity across different systems [31]. Mechanistically, ECM components can act as a reservoir for bioactive molecules and growth factors, enabling their gradual release within the host tissue [32]. This sustained biochemical signaling may modulate post-transplantation cell behavior and contribute to improved long-term regenerative outcomes. The findings of this study are consistent with previous reports investigating the use of hydrogels and ECM components to enhance cell survival and integration after transplantation [15], [32]. For instance, Laflamme et al. demonstrated improved cell survival by resuspending hPSC-derived cardiomyocytes in an ECM-based hydrogel, such as Matrigel [15]. This approach effectively prevented anoikis and improved in vivo cell viability. Similarly, Tate et al., examined the effects of a collagen I gel supplemented with laminin on the transplantation of neural stem/progenitor cells into the injured brain. They showed that transplantation within the collagen I/laminin matrix significantly increased the number of cells retained at the graft site eight weeks post-transplantation [33]. In this study, the expression of genes involved in basement membrane organization was also evaluated. FBN2 and ITGB1 showed no significant change compared with the control group, whereas NID1 was significantly upregulated in cells treated with RPE-ECM. Nidogen-1 functions as a key molecular linker within basement membranes by bridging laminin and collagen IV networks, thereby contributing to structural integrity [34]. Its upregulation suggests that ECM treatment may enhance cell- ECM interactions and facilitate improved RPE integration following transplantation. In addition, cell- derived ECMs have emerged as a promising carrier for cell transplantation. Several studies have demonstrated the potential of different cell-derived matrices as effective scaffolds for transplanted cells [35], [36]. These matrices, composed of tissue-specific structural proteins and bioactive molecules such as growth factors, play an important role in facilitating cell attachment, survival, and engraftment [19]. For example, Kim et al. reported that cell-derived ECM not only provides physical cues that promote mesenchymal stromal cells (MSCs) differentiation but also serves as a natural reservoir of cell adhesion motifs, including fibronectin, laminin, and collagen I [36]. Similarly, Schmuck et al. identified 18 bioactive molecules, including growth factors and cytokines, within cardiac fibroblast-derived ECM that are involved in key cellular processes such as adhesion, de-adhesion, proliferation, and differentiation [35]. In our study, the observed improvement in visual acuity and photoreceptor preservation following transplantation of ECM-preconditioned hiPSC-RPE cells highlights the therapeutic potential of this approach. The increased outer nuclear layer thickness suggests enhanced preservation of photoreceptor cells, which are essential for vision. In addition, the ability of the ECM-preconditioned cells to internalize shed photoreceptor outer segments further indicates their functional competence. Together with improved survival and integration of the transplanted cells, these findings suggest that ECM preconditioning enhances the capacity of hiPSC-RPE cells to support and interact with host retinal tissue. Study limitations and future directions Despite the promising results of this study, several limitations should be acknowledged. The complexity of the native basement membrane cannot be fully recapitulated by the present ECM formulation. Therefore, the observed effects may not entirely reflect cellular behavior within the physiological ECM environment. Further optimization of ECM composition and concentration is required to enhance its functional efficacy in vivo. In addition, pepsin digestion may result in partial degradation or modification of ECM components. The enzymatic activity of pepsin can alter ECM molecules through cleavage, potentially affecting their bioactivity and biomechanical properties and introducing variability in the final ECM composition and function. Accordingly, the potential impact of such modifications on cellular responses should be carefully considered [37]. Further studies are needed to elucidate the underlying molecular mechanisms and to optimize this ECM-based strategy for future translational and clinical applications. Conclusion This study demonstrates that preconditioning hPSC-RPE cells with RPE-derived ECM enhances epithelial organization in vitro and improves graft integration, photoreceptor preservation, and visual function following transplantation. These findings support the potential of ECM-based preconditioning as a promising strategy to enhance the therapeutic efficacy of hPSC-RPE cell therapy for AMD, with potential implications for improving clinical outcomes and patient quality of life. CRediT authorship contribution statement Fatemeh Sadat Hosseini Mazinani: Writing – original draft, Methodology, Investigation, Data curation. Mohammad Kazemi Ashtiani: Validation, Methodology, Conceptualization. Azadeh Moradmand: Methodology, Investigation. Leila Satarian: Writing – review & editing, Funding acquisition, Conceptualization. Funding This was supported by the Iran National Science Foundation (INSF) under project No. 97007005. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgments The authors thank the staff of the animal, histology and imaging facilities at Royan Institute for their technical assistance. Data availability Data will be made available on request. References Associated Data Data Availability Statement Data will be made available on request.